MorphaBond ER FDA Approval History
Last updated by Judith Stewart, BPharm on Feb 22, 2021.
FDA Approved: Yes (Discontinued) (First approved October 2, 2015)
Brand name: MorphaBond ER
Generic name: morphine sulfate
Dosage form: Extended-Release Tablets
Company: Inspirion Delivery Sciences
Treatment for: Pain
MorphaBond ER (morphine sulfate) is an extended-release, abuse-deterrent, opioid analgesic for the treatment of pain severe enough to require daily, around-the-clock, long-term opioid treatment.
Development timeline for MorphaBond ER
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.